Abstract:The current issue of the Journal contains the European Urinalysis Guideline (EUG) 2023 written and edited by the Task and Finish Group Urinalysis (TFG-U), working under the Science Committee of the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM). It is an update to the previous European Urinalysis Guideline published by the European Confederation of Laboratory Medicine (ECLM) in 2000 [1, 2]. After more than 20 years, these guidelines needed to be updated at least with respect to new diagnostic markers and infectious agents, development of automated particle counting, current tools of specimen collection, quality control processes and analytical performance specifications. Two crucial features are important in this updated guideline: It remains a laboratory process-oriented guideline as opposed to the most medical guidelines describing clinical perspectives of diagnostic procedures, It is an expression of fruitful co-operation between clinical chemistry and clinical microbiology laboratories since a shared single-voided urine specimen is discussed from professional knowledge of both clinical laboratory disciplines. The comprehensive document is published in seven sections covering different areas and techniques of urinalysis, with two detailed Annexes. The text describes shared test requisition strategies, preanalytical procedures, and partially even shared interpretation of analytical results. Examinations include chemical measurements with strip tests and quantitative procedures, and urine bacterial cultures with identification of species and antimicrobial susceptibility tests. Urine particle analysis represents a shared expertise, organised in either clinical chemistry or clinical microbiology laboratories in different European countries, or occasionally still performed by the nephrologists themselves. Combination of these examinations into a shared diagnostic process allows optimisation of routine urinalysis and urine bacterial culture, while specific procedures and examinations are needed in specific cases and specimens. The EFLM EUG 2023 contains numerous improvements compared to the previous ECLM guideline in 2000: The collected literature was structured based on the GRADE principles to provide levels of evidence (A–D) and strengths (1–2) to the given recommendations for laboratory tests [3, 4], as described in detail in the Introduction of the guideline. The EFLM EUG now provides a total of 65 graded recommendations in its seven sections. The assessment and grading by laboratory professionals is a new approach where reliability and consistency of laboratory examination-related evidence is assessed, for use in clinical diagnostic or prognostic outcomes. The EUG 2023 discusses medical diagnostics of urinary tract infections (UTI) and kidney disease among different patient populations as its major topics. International clinical guidelines on these provided important backgrounds, as published, e.g., by the European Urology Association [5], and the Kidney Disease Improving Global Outcomes initiative [6]. To a lesser extent, other diseases were approached mostly at a screening level if the discussed measurements are used also for other purposes, such as detection of haematuria in urothelial cancers, or proteinuria or albuminuria in pregnancy. It is obvious that a shared laboratory expertise is needed to recommend criteria for qualified testing strategies in urinalysis, adequate preanalytical processes, combination of different analytical results in points-of-care, general laboratories, and specialised laboratories, as well as relevant clinical interpretations. The established EFLM TFG-U is a multidisciplinary expert group that could benefit from special knowledge of four clinical chemists and four clinical microbiologists representing several European countries that were devoted to this task despite the COVID-19 pandemic in Europe. The EFLM TFG-U group received remarkable number of comments and suggestions for improvement into the primary draft distributed for public consultation to the National Societies of the EFLM and other stakeholders in the spring 2023. The provided 245 comments and responses to them are electronically available as Supplemental material to the guideline text. The Introduction transparently describes the details of voting among the National Societies of the EFLM. Out of 41 voting EFLM Member Societies, 28 countries replied with positive votes and 1 with negative vote – the EUG 2023 recommendations can thus be considered officially as an approved EFLM guideline. Moreover, the Guidelines Subcommittee of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) provided a public consultation for their members resulting in endorsement of the key clinical microbiology-related Sections 1, 3 and 7 of the EUG by the ESCMID. The result of this work is a landmark document for the community of laborat -Abstract Truncated-

EN ISO 15189 revision: EFLM Committee Accreditation and ISO/CEN standards (C: A/ISO) analysis and general remarks on the changes

Accreditation of medical laboratories: What is new in ISO 15189:2022

Common Nonconformities and Corrective Actions in the Assessment of Clinical Immunology Laboratory with ISO15189 Medical Laboratory Accreditation

Flexible scope for ISO 15189 accreditation: a guidance prepared by the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) Working Group Accreditation and ISO/CEN standards (WG-A/ISO)

ISO 15189 Accreditation: Navigation Between Quality Management and Patient Safety

Accreditation of the PGD laboratory

ISO 15189 is a sufficient instrument to guarantee high-quality manufacture of laboratory developed tests for in-house-use conform requirements of the European In-Vitro-Diagnostics Regulation

Harmonization and Standardization: Where Are We Now?

EFLM European Urinalysis Guideline

International Organization for Standardization (ISO) 15189

Investigation of the long-term yield of auditing for conformity with the ISO 15189:2012 quality standard in a hospital pathology laboratory

Assessing post-analytical phase harmonization in European laboratories: a survey promoted by the EFLM Working Group on Harmonization

Defining a roadmap for harmonizing quality indicators in Laboratory Medicine: a consensus statement on behalf of the IFCC Working Group “Laboratory Error and Patient Safety” and EFLM Task and Finish Group “Performance specifications for the extra-analytical phases”

Compliance to specifications in an external quality assurance program: did new biological variation estimates of the European Federation of Laboratory Medicine (EFLM) affect the quality of laboratory results?

FELASA accreditation of education and training courses in laboratory animal science according to the Directive 2010/63/EU

Summary analysis on accreditation on-site review nonconformity items of 18 medical laboratories in Shanghai

Standards in semen examination: publishing reproducible and reliable data based on high-quality methodology

Laboratory-Developed Tests: Design of a Regulatory Strategy in Compliance with the International State-of-the-Art and the Regulation (EU) 2017/746 (EU IVDR [In Vitro Diagnostic Medical Device Regulation])

European Council of Legal Medicine (ECLM) accreditation of forensic pathology services in Europe

Strategies to define performance specifications in laboratory medicine: 3 years on from the Milan Strategic Conference

Implementation of the laboratory quality management system (ISO 15189): Experience from Bugando Medical Centre Clinical Laboratory – Mwanza, Tanzania